In this episode of the Diabetes Innovators Series, Rob interviews Jonathan Rigby, CEO of Sernova Biotherapeutics, about the innovative approaches to treating type 1 diabetes, particularly through the development of a biohybrid organ known as the cell pouch. Jonathan shares his personal journey as a type 1 diabetic and discusses the clinical trials, patient selection, and the future of diabetes treatment, including the challenges of immunosuppression and the complexities of daily diabetes management. The conversation emphasizes the importance of innovation in diabetes care and the hope for a future where patients can achieve insulin independence.
Chapters
00:00 Introduction to Diabetes and Innovation
02:51 The Cell Pouch Biohybrid Organ
05:53 Clinical Trials and Patient Selection
08:48 Living with Type 1 Diabetes
11:51 Future of Diabetes Treatment
14:47 Immunosuppressants and Cell Acceptance
17:48 The Complexity of Diabetes Management
20:44 Conclusion and Future Outlook
Resources:
